# Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension

> **NCT00913094** · — · UNKNOWN · sponsor: **CardioDynamics** · enrollment: 200 (estimated)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00913094
- **Lead sponsor:** CardioDynamics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913094, "Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00913094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*